NEUROENDOCRINE NEOPLASM
Clinical trials for NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial pits two drug cocktails against Hard-to-Treat cancers
Disease control OngoingThis study compares two drug combinations for people with advanced neuroendocrine tumors (carcinoid cancer) that cannot be removed by surgery. Participants receive either octreotide plus interferon or octreotide plus bevacizumab. The goal is to see which combination better slows …
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
Drug cocktail shows promise for rare gut tumors
Disease control OngoingThis study tests two drugs, lenvatinib and everolimus, together in people with advanced carcinoid tumors that cannot be removed by surgery. The goal is to see if the combination can shrink tumors or slow their growth. The trial includes 36 adults with measurable disease, and rese…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 18, 2026 11:49 UTC
-
New combo therapy targets Hard-to-Treat gut tumors
Disease control OngoingThis early-phase trial tests a new drug (peposertib) combined with a radioactive therapy (lutetium 177 dotatate) for people with a type of slow-growing gut and pancreas cancer called neuroendocrine tumors. The goal is to find the safest dose and see if the combination shrinks tum…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:46 UTC
-
New drug shows promise in slowing advanced neuroendocrine tumors
Disease control OngoingThis study tests whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors (including carcinoid tumors) compared to a placebo. About 298 adults whose cancer worsened after prior treatment will receive either cabozantinib or a placebo pill. The main goal …
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
New combo therapy shows promise for Hard-to-Treat neuroendocrine liver tumors
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to either liver-directed treatments (like ablation or radiation) or peptide receptor radionuclide therapy (PRRT) can shrink or control well-differentiated neuroendocrine tumors that have spread to the liver and …
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: Nicholas Fidelman, MD • Aim: Disease control
Last updated Jun 09, 2026 12:06 UTC
-
New PET tracer could light up cancers for better detection
Diagnosis OngoingThis early-phase study is testing a new imaging tracer called 68Ga-FAPI-46, which targets a protein (FAP) found around many tumors. Researchers will give the tracer to 26 patients with various cancers and use PET/CT scans to see where it goes in the body. They will also compare t…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 23, 2026 11:55 UTC